We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our
Privacy Policy
.
Yes, I accept
Menu
Corporate Members
E-Library
Twitter
Linked In
Facebook
Instagram
Join
MyESTRO
Search Opener
Search for:
About ESTRO
Membership
School
Workshops
Congresses
Science
Education
Advocacy
Corporate Members
E-Library
Home
Congresses
ESTRO 2025
Programme
RTT treatment planning, OAR and target...
02 May 2025 - 06 May 2025
Vienna, Austria
ESTRO 2025
Session
RTT treatment planning, OAR and target definitions
Session Type:
Digital Poster
Track:
RTT
Journey:
Add to
My Programme
Adaptive bladder new proposed lateral margins.
Presenter
:
Roeum Butt
,
United Kingdom
Presentation Number:
E25-177
an evaluation of the accuracy of deep learning-based auto segmentation for organs at risk delineation in the radiotherapy of left breast cancer
Presenter
:
Christy Yan Yan Poon
,
Hong Kong (SAR) China
Presentation Number:
E25-792
The role of PET/CT in radiotherapy planning for anal squamous cell carcinoma (SCC): changes in staging and pathway timeliness.
Presenter
:
Joanna Meng
,
United Kingdom
Presentation Number:
E25-1126
agreement between 4D-CT and data-driven 18F-FDG-PET respiratory gating for radiotherapy planning
Presenter
:
Pooneh Porrangi
,
Iran Islamic Republic of
Presentation Number:
E25-1149
Dosimetric analysis of nodal breast VMAT using a High-Definition MLC
Presenter
:
Juan-Francisco Calvo-Ortega
,
Spain
Presentation Number:
E25-1265
A comparative analysis of the dosimetric benefits of the library of plans and daily online adaptation on MR-Linac for cervical cancer
Presenter
:
Cynthia Eccles
,
United Kingdom
Presentation Number:
E25-1317
Analysing Replanning Contributing Factors to Standardise Adaptive Head and Neck Proton Therapy
Presenter
:
Sze Yarn Sin
,
Singapore
Presentation Number:
E25-1605
Quantification of the dosimetric impact of the iBeam Evo couchtop (Elekta) connection in VMAT
Presenter
:
Ines Flores-Cacho
,
Spain
Presentation Number:
E25-1617
Implementation of Mid-Ventilation Stereotactic Ablative Body Radiotherapy (SABR) for Stage I Non-Small Cell Lung Carcinoma (NSCLC)
Presenter
:
Kendell Dowton
,
Australia
Presentation Number:
E25-1759
Comparison of target volume changes in T2W and DWI with ADC and cumulative delivered dose in muscle invasive bladder cancer
Presenter
:
James Tallon
,
United Kingdom
Presentation Number:
E25-1817
Breast cancer: Anatomical parameters for optimizing personalized radiotherapy
Presenter
:
Francesco Cocco
,
Italy
Presentation Number:
E25-1873
Dosimetric comparison between co-planar VMAT and HyperArc in treating skull base meningioma with fractionated stereotactic radiotherapy
Presenter
:
Wong Tin Long
,
Hong Kong (SAR) China
Presentation Number:
E25-316
Internal validation of two AI-based autocontouring softwares
Presenter
:
João Dias
,
Portugal
Presentation Number:
E25-1961
Humeral heads radiation exposure in breast cancer radiotherapy: How does VMAT compare to 3D conformal radiotherapy?
Presenter
:
Zeineb Naimi
,
Tunisia
Presentation Number:
E25-2178
Integration and governance of MIM software in a multi-site institution.
Presenter
:
Craig Norvill
,
Australia
Presentation Number:
E25-2272
Quantitative evaluation of tumor subregion automatic segmentation in glioblastoma for monitoring of growth patterns
Presenter
:
Charlotte Robert
,
France
Presentation Number:
E25-2346
Hypofractionated whole pelvic VMAT for high risk prostate cancer: Are OAR dose constraints easily achievable?
Presenter
:
Zeineb Naimi
,
Tunisia
Presentation Number:
E25-2429
Correlation between Gradient Index and Target Volume: Single Institution Experience in Linac-based Radiosurgery of Brain Metastasis
Presenter
:
Fernando Costa
,
Portugal
Presentation Number:
E25-2505
Evaluation of SAM and SAM2 from clinical perspective for organ delineation
Presenter
:
Borbála Deák-Karancsi
,
Hungary
Presentation Number:
E25-2511
Validation of Deep Learning-Based Dose Prediction for Prostate SBRT: A Dosimetric Comparison Study
Presenter
:
Dániel Gugyerás
,
Hungary
Presentation Number:
E25-2736
Abdominal Compression vs Non-Abdominal Compression Planning CT for Cardiac Stereotactic Ablative Radiotherapy (cSABR)
Presenter
:
Caroline Sisodia
,
United Kingdom
Presentation Number:
E25-2738
Clinical Target Volume (CTV) to Planning Target Volume (PTV) margin expansions for gynecological patients undergoing extended field radiotherapy.
Presenter
:
Rayna Quey
,
Singapore
Presentation Number:
E25-329
Dosimetric Evaluation of Superficial Parotid Lobe Sparing IMRT Techniques for Nasopharyngeal Carcinoma: Insights on Feasibility and Trade-offs
Presenter
:
Pui Lam Yip
,
Hong Kong (SAR) China
Presentation Number:
E25-2758
Dosimetric advantages and clinical feasibility of the set up of a new lateral decubitus position in patients with left breast cancer undergoing PORT
Presenter
:
Yingying Zhou
,
China
Presentation Number:
E25-2808
Rigid propagation of target structures facilitates RTT-led online adaptive radiotherapy (oART) of prostate and elective lymph nodes (Ethos/CBCT-based)
Presenter
:
Leslie Harrison
,
Denmark
Presentation Number:
E25-2955
Volume changes in prostate cancer patients during the course of MRI-guided radiotherapy
Presenter
:
Sanne Conijn
,
The Netherlands
Presentation Number:
E25-2999
Artificial Intelligence contouring in radiotherapy for organs-at-risk and lymph node areas
Presenter
:
MEYER Celine
,
France
Presentation Number:
E25-3104
Utilization of three AI-driven anatomical organ delineation software and evaluation of their efficacy in radiotherapy treatment planning
Presenter
:
Gergely Bungyi
,
Hungary
Presentation Number:
E25-3434
Initial evaluation of AI-contoured OARs in CBCT-guided online adaptive radiotherapy for focal bladder and cervical cancer
Presenter
:
A. Bel
,
The Netherlands
Presentation Number:
E25-3473
dosimetric evaluation to the cardiac substructures in a cohort of patients with breast cancer treated with fast forward schedule radiotherapy
Presenter
:
Daniela Patrizia Doino
,
Italy
Presentation Number:
E25-3667
Evaluation of the utility of spaceOAR in hypofractionated radiation therapy for prostate cancer
Presenter
:
Kyung min Yoo
,
Korea Republic of
Presentation Number:
E25-3699
Analysis and comparison of CyberKnife MLC collimator versus IRIS collimator in prostate SBRT
Presenter
:
Marcello Serra
,
Italy
Presentation Number:
E25-3734
OPTIMIZED LEFT BREAST CANCER RADIOTHERAPY: BETTER HEART PRESERVATION
Presenter
:
ferdaws friaa
,
Tunisia
Presentation Number:
E25-376
CAN AUTOGENERATED TREATMENT PLANS REPLACE THOSE MADE MANUALLY BY TREATMENT PLANNERS?
Presenter
:
Malin Apelman
,
Sweden
Presentation Number:
E25-3795
Inter-fraction motion evaluation of the internal pudendal arteries during a stereotactic irradiation of prostate cancer using the 1.5T MR-Linac
Presenter
:
Olivier Chapet
,
France
Presentation Number:
E25-3887
Analysis of Feasibility and Robustness of Proton Beam Therapy for Treating Vulva Cancer using Cone beam computed tomography: A planning study
Presenter
:
Vossco Nguyen
,
United Kingdom
Presentation Number:
E25-3900
Multi-disciplinary inter- and intra-observer variability for manual and AI-based contouring of thoracic organs at risk.
Presenter
:
Keeva Moran
,
Ireland
Presentation Number:
E25-3937
Advanced-technique radiation therapy for prostate cancer in an emerging oncology centre of excellence in sub-Saharan Africa
Presenter
:
muhammad habeebu
,
Nigeria
Presentation Number:
E25-3981
An approach to internal target volume margins for kidney SBRT on the MR-Linac
Presenter
:
Jennifer Dang
,
Canada
Presentation Number:
E25-4088
Upright radiotherapy for breast cancer: considering photon beam access and arm positioning
Presenter
:
Tracy Underwood
,
United Kingdom
Presentation Number:
E25-4154
Validation Of An In-House AI-Segmentation Algorithm For The Delineation of Head and Neck Organs At Risk
Presenter
:
Susan Mercieca
,
Malta
Presentation Number:
E25-4204
PARTIAL BREAST IRRADIATION: FREE BREATHING VERSUS DEEP INSPIRATORY BREATH HOLD
Presenter
:
Patrícia Varzim
,
Portugal
Presentation Number:
E25-4217
Clinical evaluation of the performance of three deep learning contouring model in head-and neck region for radiotherapy
Presenter
:
Adam Miovecz
,
Hungary
Presentation Number:
E25-4335
Implementation of a VMAT technique to treat breast/chest wall cancer patients with level 3 and/or 4 nodal involvement
Presenter
:
Matthew Brennan
,
United Kingdom
Presentation Number:
E25-644
Assessment of lacrimal gland dose in patients treated with radiotherapy for nasopharyngeal carcinoma
Presenter
:
Amal Chamsi
,
Tunisia
Presentation Number:
E25-4362
Hypofractionated radiotherapy for breast cancer after mastectomy : can dosimetric constraints be achieved ?
Presenter
:
Samia Kanoun
,
Tunisia
Presentation Number:
E25-4411
Proposed method for optimization of Lattice Radiation Therapy using an advanced ring gantry linac
Presenter
:
Milton Ixquiac
,
Guatemala
Presentation Number:
E25-4559
Delineation of non-small cell lung cancer gross tumour volume on cone beam CT images: a feasibility study including auto-segmentation
Presenter
:
Sarah Barrett
,
Ireland
Presentation Number:
E25-4574
Head and Neck Cancer Radiation Treatment Peer Review Outcomes in a Shared Care Model
Presenter
:
Laura D'Alimonte
,
Canada
Presentation Number:
E25-4613
Evaluation of the dosimetric impact of bladder variability on a cervical cancer cohort
Presenter
:
Claire Nelder
,
United Kingdom
Presentation Number:
E25-701
Evaluation of Transformer Architecture for Deepdose Prediction in Radiotherapy
Presenter
:
Nikos Paragios
,
France
Presentation Number:
E25-768
A retrospective analysis of achievability of recommended dose constraints in VMAT plans for breast cancer plus regional nodes irradiation
Presenter
:
Juan-Francisco Calvo-Ortega
,
Spain
Presentation Number:
E25-771
Plan quality variability in radiotherapy of whole breast and regional lymph nodes: an intra-institutional analysis
Presenter
:
Gracinda Johansson
,
Sweden
Presentation Number:
E25-786
E-Mail Address
Please enter a user name
Password
Cancel
Forgotten Password
Create MyESTRO Account
i
Please log in to add this session to your programme.